Steven LeBoeuf

Valencell, Inc, USA

Abstract available soon.

About the Speaker

Inventor of more than 80 granted patents and more than 100 patents pending in the field of wearable biomedical sensing, Steven LeBoeuf is one of the foundational innovators in wearable PPG sensors that are now embedded in millions of wearables on the market today. Before founding Valencell in 2006, Dr. LeBoeuf pioneered innovations in solid state materials, multiwavelength optoelectronic devices, high-power electronics, nanostructured materials and devices, and biochemical sensor systems while serving as a Senior Scientist and Biosensor Project Lead for General Electric. LeBoeuf has developed dozens of strategic partnerships with industry leading consumer technology brands, medical professionals, research institutions, medical device manufacturers, health and fitness companies, and start-ups. One of the most broadly quoted scientists and entrepreneurs in the field of wearable PPG sensing, LeBoeuf has served as a speaker in 50+ events around the world and is routinely interviewed by journalists, industry analysts, venture capitalists, and academic researchers. As a founding pioneer in modern wearables, LeBoeuf has managed Valencell’s foundational patent portfolio, which has been licensed to dozens of companies around the world and implemented in 40+ wearable devices, ranging from earbuds, hearing aids, wristbands, legbands, smartwatches, virtual reality systems, headbands and more. LeBoeuf holds a PhD in Electrical Engineering from North Carolina State University and BS degree in Electrical Engineering and Mathematics at Louisiana Tech University.

Inventor of more than 80 granted patents and more than 100 patents pending in the field of wearable biomedical sensing, Steven LeBoeuf is one of the foundational innovators in wearable PPG sensors...

Bruce Tromberg

National Institute of Biomedical Imaging and Bioengineering, USA

Abstract available soon.

About the Speaker

Bruce J. Tromberg is Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH, a post he assumed in January 2019. He is a pioneering leader in the field of biophotonics. Prior to his appointment at NIBIB, Dr. Tromberg held dual appointments as professor in the Departments of Biomedical Engineering and Surgery at the University of California at Irvine (UCI). He also directed UCI’s Beckman Laser Institute and Medical Clinic, an interdisciplinary research, teaching and clinical center for optics and photonics in biology and medicine. In his 30-plus-year academic and scientific career, Dr. Tromberg conducted extensive NIH-supported research, and was the principal investigator (PI) for multiple NIH grants going back as far as 1994. This includes 20 years as PI for the Laser Microbeam and Medical Program (LAMMP), an NIH National Biomedical Technology Resource Center where several cutting-edge technologies have been developed and disseminated to laboratories and clinics around the world. Dr. Tromberg's research spans biophotonics and biomedical optics, two rapidly growing fields that use light to image and conduct therapy at the molecular, cellular and tissue levels. He specializes in new technology development as well as the “bench to bedside” clinical translation, validation and commercialization of promising methods designed to improve human health.

Bruce J. Tromberg is Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH, a post he assumed in January 2019. He is a pioneering leader in the field of...

Catharine Young

Consultant, USA

The Optics of a Changing Scientific Landscape

Abstract available soon.

About the Speaker

Originally from South Africa, Dr. Catharine Young holds a doctorate degree in Biomedical Sciences and previously served as the Senior Director of Science Policy for the Biden Cancer Initiative. Here she fostered discussion and collaboration within the biotech, technology, science, and academic fields to drive innovation solutions and breakthroughs against cancer. Prior to this position, Catharine served as the Senior Science and Innovation Policy Advisor and Head of the DC team for the Foreign Ministry of the UK. Based at the British Embassy, Catharine influenced science and innovation policies of both the UK and US governments, industry, and academia. Following her Postdoctoral training at Cornell University in Biomedical Engineering, Catharine was selected as a AAAS Science and Technology Policy Fellow in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. Here she led international engagements on eliminating biological weapons, improving biosafety and biosecurity, and assisting in the DoD's response to the Ebola outbreak in Western Africa. Catharine also co-founded Blueprint International, a non-profit dedicated to providing novel technological solutions to some of the world’s most pressing social issues. Recent awards include being selected as a TED Fellow, Alexandria 40 Under 40 and Social Enablers top 100 most inspiring social entrepreneurs. Catharine is an advocate for women in STEM and has been a contributor to major social and media networks including TED-Ed, the Guardian and the UK Science and Innovation Network.

Originally from South Africa, Dr. Catharine Young holds a doctorate degree in Biomedical Sciences and previously served as the Senior Director of Science Policy for the Biden Cancer Initiative...